Literature DB >> 25232554

Champagne bottle neck sign in a patient with Moyamoya syndrome.

Takafumi Shimogawa1, Takato Morioka1, Tetsuro Sayama1, Takeshi Hamamura1, Chiharu Yasuda1, Shuji Arakawa1.   

Abstract

The champagne bottle neck (CBN) sign refers to a reduction in the diameter of the proximal portion of the internal carotid artery that resembles a CBN, and is a characteristic feature of Moyamoya disease. A 43-year-old woman with an infarction of the posterior limb of the left internal capsule was diagnosed with Moyamoya syndrome associated with Graves' disease. The CBN sign was observed bilaterally. Cerebral revascularization surgery was performed, including left-sided superficial temporal artery to middle cerebral artery anastomosis. During four years of follow-up, she maintained a euthyroid state and did not have any further cerebral ischemic events. The CBN signs remained unchanged on both sides during this time. This is the first report of the CBN sign in a patient with Moyamoya syndrome associated with Graves' disease.

Entities:  

Keywords:  Champagne bottle neck sign; Graves’ disease; Moyamoya disease; Moyamoya syndrome; Revascularization

Year:  2014        PMID: 25232554      PMCID: PMC4163773          DOI: 10.12998/wjcc.v2.i9.474

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  18 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Variable extension of the transitional zone in the medial structure of carotid artery tripod.

Authors:  J Janzen; P Lanzer; K Rothenberger-Janzen; P N Vuong
Journal:  Vasa       Date:  2001-05       Impact factor: 1.961

3.  Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease.

Authors:  Hidenori Endo; Miki Fujimura; Kuniyasu Niizuma; Hiroaki Shimizu; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

Review 4.  Moyamoya syndrome associated with Graves' disease: a case report and review of the literature.

Authors:  Shaneela Malik; Andrew N Russman; Angelos M Katramados; Brian Silver; Panayiotis D Mitsias
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-12-04       Impact factor: 2.136

5.  Changes in vascular reactivity induced by acute hyperthyroidism in isolated rat aortae.

Authors:  H Honda; T Iwata; T Mochizuki; H Kogo
Journal:  Gen Pharmacol       Date:  2000-06

6.  Reversible MR angiographic findings in a patient with autoimmune Graves disease.

Authors:  Ufuk Utku; Talip Asil; Yahya Celik; Dilek Tucer
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

7.  Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.

Authors:  So-Hyang Im; Chang Wan Oh; O-Ki Kwon; Jung Eun Kim; Dae Hee Han
Journal:  J Neurosurg       Date:  2005-06       Impact factor: 5.115

8.  Familial moyamoya disease associated with Graves' disease in a mother and daughter. Two case reports.

Authors:  Hiroshi Tokimura; Kenichiro Tajitsu; Hiroshi Takashima; Takahisa Hirayama; Masahiro Tsuchiya; Kenji Takayama; Kazunori Arita
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

Review 9.  Moyamoya disease: a summary.

Authors:  Gordon M Burke; Allan M Burke; Arun K Sherma; Michael C Hurley; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

10.  Increased stiffness in common carotid artery in hyperthyroid Graves' disease patients.

Authors:  M Inaba; Y Henmi; Y Kumeda; M Ueda; M Nagata; M Emoto; T Ishikawa; E Ishimura; Y Nishizawa
Journal:  Biomed Pharmacother       Date:  2002-07       Impact factor: 6.529

View more
  1 in total

1.  The angiographic presentation of European Moyamoya angiopathy.

Authors:  Sara Pilgram-Pastor; René Chapot; Markus Kraemer
Journal:  J Neurol       Date:  2021-07-08       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.